Lewei Lin
Biographic Data
| ID | 7829528 |
|---|---|
| NAME | Lewei Lin |
| GIVEN NAMES | Lewei |
| FAMILY NAME | Lin |
| SIGNATURE | LIN L |
| AFFILIATIONS | University of Michigan |
| ORCID | 0000-0003-2765-7814 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
In this serial cross-sectional study of Medicaid PA policies for buprenorphine for OUD, removal of PAs was not associated with overall changes in buprenorphine prescribing among Medicaid enrollees. Given the ongoing burden of opioid overdoses, continued multipronged efforts are needed to remove barriers to buprenorphine care and increase availability of this lifesaving treatment
Gender Differences in Patterns and Correlates of Continued Substance Use among Patients in Methadone Maintenance Treatment
Background Continued substance use is common during opioid use disorder (OUD) treatment. There are still inconsistencies in how continued substance use and concurrent patterns of substance use among patients with OUD varies by gender. There is still more to learn regarding how factors associated with continued and concurrent use might differ for men and women in methadone maintenance treatment (MMT). Methods: This cross-sectional study examined p…
Longitudinal within- and between-person associations of substance use, social influences, and loneliness among adolescents and emerging adults who use drugs
Loneliness is a public health problem causing morbidity and mortality. Individuals with substance use problems are often lonelier than the general population. We evaluate the longitudinal associations between social influences, substance use, and loneliness among adolescents and young adults recruited from an urban Emergency Department (ED). We use secondary data from a natural history study of N=599 youth (ages 14-24) who used drugs at baseline …
Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis
BACKGROUND: Any opioid-related hospitalization is an indicator of opioid-related harm and should ideally trigger carefully monitored decreases in opioid prescribing after inpatient stays in many, if not most, cases. However, past studies on opioid prescribing after hospitalizations have largely been limited to overdose related visits. It is unclear whether prescribing is different for other opioid-related indications such as opioid dependence and…
Trajectories of nonmedical use of prescription opioids among adolescents in primary care
Background: Rise in nonmedical use of prescription opioids (NMUPO) is an emerging public health problem in adolescents. To better understand risk factors for NMUPO and patterns of use over time, we examined trajectories of NMUPO among a sample of adolescents who presented to primary care clinics.Methods: Data were from 1076 adolescents ages 12–18, primarily African–American (62.6%) enrolled in a randomized controlled trial. Data were collected at…
No prominent works on this page.
Trajectories of nonmedical use of prescription opioids among adolescents in primary care
Background: Rise in nonmedical use of prescription opioids (NMUPO) is an emerging public health problem in adolescents. To better understand risk factors for NMUPO and patterns of use over time, we examined trajectories of NMUPO among a sample of adolescents who presented to primary care clinics.Methods: Data were from 1076 adolescents ages 12–18, primarily African–American (62.6%) enrolled in a randomized controlled trial. Data were collected at…
Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis
BACKGROUND: Any opioid-related hospitalization is an indicator of opioid-related harm and should ideally trigger carefully monitored decreases in opioid prescribing after inpatient stays in many, if not most, cases. However, past studies on opioid prescribing after hospitalizations have largely been limited to overdose related visits. It is unclear whether prescribing is different for other opioid-related indications such as opioid dependence and…
Gender Differences in Patterns and Correlates of Continued Substance Use among Patients in Methadone Maintenance Treatment
Background Continued substance use is common during opioid use disorder (OUD) treatment. There are still inconsistencies in how continued substance use and concurrent patterns of substance use among patients with OUD varies by gender. There is still more to learn regarding how factors associated with continued and concurrent use might differ for men and women in methadone maintenance treatment (MMT). Methods: This cross-sectional study examined p…
Longitudinal within- and between-person associations of substance use, social influences, and loneliness among adolescents and emerging adults who use drugs
Loneliness is a public health problem causing morbidity and mortality. Individuals with substance use problems are often lonelier than the general population. We evaluate the longitudinal associations between social influences, substance use, and loneliness among adolescents and young adults recruited from an urban Emergency Department (ED). We use secondary data from a natural history study of N=599 youth (ages 14-24) who used drugs at baseline …
Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
In this serial cross-sectional study of Medicaid PA policies for buprenorphine for OUD, removal of PAs was not associated with overall changes in buprenorphine prescribing among Medicaid enrollees. Given the ongoing burden of opioid overdoses, continued multipronged efforts are needed to remove barriers to buprenorphine care and increase availability of this lifesaving treatment
Medicine (5 works) · Internal Medicine (4 works) · Opioid Use Disorder Treatment (4 works) · Substance Abuse Treatment and Outcomes (4 works) · Medical prescription (3 works) · Opioid (3 works) · Prenatal Substance Exposure Effects (3 works) · Psychiatry (3 works) · Buprenorphine (2 works) · Cannabis (2 works)